# RDF export of group: Publication
<http://ctro/data#Publication_47597> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_47597> <http://www.w3.org/2000/01/rdf-schema#label> "Publication " .
<http://ctro/data#Publication_47597> <http://ctro/data#hasTitle> "Efficacy and safety of the dipeptidyl peptidase - 4 inhibitor , sitagliptin , in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin ." .
<http://ctro/data#Publication_47597> <http://ctro/data#hasAuthor> "Hermansen K" .
<http://ctro/data#Publication_47597> <http://ctro/data#hasPublicationYear> "2007" .
<http://ctro/data#Publication_47597> <http://ctro/data#hasJournal> "Diabetes Obes Metab ." .
<http://ctro/data#Publication_47597> <http://ctro/data#hasPMID> "17593236" .
<http://ctro/data#Publication_47597> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_47609> .
<http://ctro/data#Publication_47597> <http://ctro/data#hasAuthor> "Kipnes M" .
<http://ctro/data#Publication_47597> <http://ctro/data#hasAuthor> "Luo E" .
<http://ctro/data#Publication_47597> <http://ctro/data#hasAuthor> "Fanurik D" .
<http://ctro/data#Publication_47597> <http://ctro/data#hasAuthor> "Khatami H" .
<http://ctro/data#Publication_47597> <http://ctro/data#hasAuthor> "Stein P" .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_47609> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_47609> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial " .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasObjectiveDescription> "To assess the efficacy and safety of a 24 - week treatment with sitagliptin , a highly selective once - daily oral dipeptidyl peptidase - 4 ( DPP - 4 ) inhibitor ," .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasNumberPatientsCT> "441" .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasCTduration> "24 - week" .
<http://ctro/data#AllocationRatio_47613> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasAllocationRatio> <http://ctro/data#AllocationRatio_47613> .
<http://ctro/data#CTAnalysisApproach_47614> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasConclusionComment> "Sitagliptin 100 mg once daily significantly improved glycaemic control and beta - cell function in patients with type 2 diabetes who had inadequate glycaemic control with glimepiride or glimepiride plus metformin therapy ." .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasArm> <http://ctro/data#Arm_47897> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes> .
<http://ctro/data#Population_47619> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_72302> .
<http://ctro/data#EvidenceQuality_47621> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasObjectiveDescription> "in patients with type 2 diabetes who had inadequate glycaemic control [ glycosylated haemoglobin ( HbA ( 1c ) ) > or = 7 . 5 % and < or = 10 . 5 % ] while on glimepiride alone or in combination with metformin ." .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasConclusionComment> "The addition of sitagliptin was generally well tolerated , with a modest increase in hypoglycaemia and body weight , consistent with glimepiride therapy and the observed degree of glycaemic improvement ." .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_92421> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_92484> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_92547> .
<http://ctro/data#ClinicalTrial_47609> <http://ctro/data#hasArm> <http://ctro/data#Arm_47976> .
# RDF export of group: Population
<http://ctro/data#Population_47630> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_47630> <http://www.w3.org/2000/01/rdf-schema#label> "Population " .
<http://ctro/data#Population_47630> <http://ctro/data#hasPrecondition> "patients with type 2 diabetes who had inadequate glycaemic control [ glycosylated haemoglobin ( HbA ( 1c ) ) > or = 7 . 5 % and < or = 10 . 5 % ] while on glimepiride alone or in combination with metformin" .
<http://ctro/data#Ethnicity_47632> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Country_47633> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Country> .
<http://ctro/data#Population_47630> <http://ctro/data#hasCountry> <http://ctro/data#Country_47633> .
<http://ctro/data#Population_47630> <http://ctro/data#hasMinAge> "18" .
<http://ctro/data#Population_47630> <http://ctro/data#hasMaxAge> "75" .
<http://ctro/data#Gender_47637> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_47638> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_47638> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint hba1c" .
<http://ctro/data#Endpoint_47638> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c> .
<http://ctro/data#Mean_47640> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_47638> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_47640> .
<http://ctro/data#Endpoint_47638> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_47642> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_47643> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_47643> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint fpg" .
<http://ctro/data#Endpoint_47643> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose> .
<http://ctro/data#AggregationMethod_47645> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_47643> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Mg_per_deciliter> .
<http://ctro/data#MeasurementDevice_47647> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_47648> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_47648> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint hmab" .
<http://ctro/data#EndPointDescription_47649> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription> .
<http://ctro/data#Endpoint_47648> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_47649> .
<http://ctro/data#AggregationMethod_47650> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_47651> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_47652> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_47653> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_47653> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint ppg" .
<http://ctro/data#Endpoint_47653> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#PostprandialBloodGlucose> .
<http://ctro/data#AggregationMethod_47655> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_47656> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_47657> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
# RDF export of group: Arm
<http://ctro/data#Arm_47897> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_47897> <http://www.w3.org/2000/01/rdf-schema#label> "Arm s" .
<http://ctro/data#Arm_47897> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_47922> .
<http://ctro/data#Arm_47897> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_47985> .
<http://ctro/data#Outcome_47902> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Arm_47976> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_47976> <http://www.w3.org/2000/01/rdf-schema#label> "Arm p" .
<http://ctro/data#Arm_47976> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_47961> .
<http://ctro/data#Arm_47976> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_48039> .
<http://ctro/data#Outcome_47981> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_47922> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_47922> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention s" .
<http://ctro/data#Intervention_47922> <http://ctro/data#hasMedication> <http://ctro/data#Medication_47915> .
<http://ctro/data#Intervention_47922> <http://ctro/data#hasFrequency> "once daily" .
<http://ctro/data#RelativeTime_47927> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_47961> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_47961> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention p" .
<http://ctro/data#Intervention_47961> <http://ctro/data#hasMedication> <http://ctro/data#Medication_47928> .
<http://ctro/data#RelativeTime_47966> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
# RDF export of group: Medication
<http://ctro/data#Medication_47915> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_47915> <http://www.w3.org/2000/01/rdf-schema#label> "Medication s" .
<http://ctro/data#Medication_47915> <http://ctro/data#hasDrug> <http://ctro/data#Sitagliptin> .
<http://ctro/data#Medication_47915> <http://ctro/data#hasDoseValue> "100" .
<http://ctro/data#Medication_47915> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg> .
<http://ctro/data#DeliveryMethod_47919> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_47928> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_47928> <http://www.w3.org/2000/01/rdf-schema#label> "Medication p" .
<http://ctro/data#Medication_47928> <http://ctro/data#hasDrug> <http://ctro/data#Placebo> .
<http://ctro/data#BioAndMedicalUnit_47931> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_47932> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
# RDF export of group: Outcome
<http://ctro/data#Outcome_47985> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_47985> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome hba1c s" .
<http://ctro/data#Outcome_47985> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_47638> .
<http://ctro/data#Outcome_47985> <http://ctro/data#hasBaselineValue> "8 . 34" .
<http://ctro/data#Outcome_48039> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_48039> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome hba1c p" .
<http://ctro/data#Outcome_48039> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_47638> .
<http://ctro/data#Outcome_48039> <http://ctro/data#hasBaselineValue> "8 . 34" .
<http://ctro/data#Outcome_92367> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_92367> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome FPG s" .
<http://ctro/data#Outcome_92367> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_47643> .
<http://ctro/data#Outcome_92394> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_92394> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome FPG p" .
<http://ctro/data#Outcome_92394> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_47643> .
<http://ctro/data#Outcome_92430> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_92430> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome ppg s" .
<http://ctro/data#Outcome_92430> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_47653> .
<http://ctro/data#Outcome_92457> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_92457> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome ppg p" .
<http://ctro/data#Outcome_92457> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_47653> .
<http://ctro/data#Outcome_92493> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_92493> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome hmab s" .
<http://ctro/data#Outcome_92493> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_47648> .
<http://ctro/data#Outcome_92520> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_92520> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome hmab p" .
<http://ctro/data#Outcome_92520> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_47648> .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_72302> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_72302> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups hba1c" .
<http://ctro/data#DiffBetweenGroups_72302> <http://ctro/data#hasDiffGroupAbsValue> "0 . 74" .
<http://ctro/data#DiffBetweenGroups_72302> <http://ctro/data#hasPvalueDiff> "p < 0 . 001" .
<http://ctro/data#DiffBetweenGroups_72302> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_47985> .
<http://ctro/data#DiffBetweenGroups_72302> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_48039> .
<http://ctro/data#DiffBetweenGroups_92421> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_92421> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups FPG" .
<http://ctro/data#DiffBetweenGroups_92421> <http://ctro/data#hasDiffGroupAbsValue> "20 . 1" .
<http://ctro/data#DiffBetweenGroups_92421> <http://ctro/data#hasPvalueDiff> "p < 0 . 001" .
<http://ctro/data#DiffBetweenGroups_92421> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_92367> .
<http://ctro/data#DiffBetweenGroups_92421> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_92394> .
<http://ctro/data#DiffBetweenGroups_92484> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_92484> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups ppg" .
<http://ctro/data#DiffBetweenGroups_92484> <http://ctro/data#hasDiffGroupAbsValue> "36 . 1" .
<http://ctro/data#DiffBetweenGroups_92484> <http://ctro/data#hasPvalueDiff> "p < 0 . 001" .
<http://ctro/data#DiffBetweenGroups_92484> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_92430> .
<http://ctro/data#DiffBetweenGroups_92484> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_92457> .
<http://ctro/data#DiffBetweenGroups_92547> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_92547> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups hmab" .
<http://ctro/data#DiffBetweenGroups_92547> <http://ctro/data#hasDiffGroupRelValue> "12" .
<http://ctro/data#DiffBetweenGroups_92547> <http://ctro/data#hasPvalueDiff> "p < 0 . 05" .
<http://ctro/data#DiffBetweenGroups_92547> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_92493> .
<http://ctro/data#DiffBetweenGroups_92547> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_92520> .
# RDF export of group: EvidenceQuality